CN Stock MarketDetailed Quotes
600993 Mayinglong Pharmaceutical Group
- 26.53
- -0.63-2.32%
Market Closed Dec 13 15:00 CST
11.44BMarket Cap23.71P/E (TTM)
27.07High26.46Low54.66KlotVolume27.00Open27.16Pre Close145.82MTurnover1.27%Turnover Ratio25.81P/E (Static)431.05MShares30.7852wk High2.86P/B11.42BFloat Cap19.8052wk Low29.88Limit Up430.31MShs Float37.93Historical High24.44Limit Down2.25%Amplitude-1.11Historical Low0.40Dividend TTM26.68Avg Price29.54KlotAsk1.51%Div YieldTTM100Lot Size22.57KlotBid
Mayinglong Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 16.44%2.33B | 17.62%2.44B | 9.32%2.41B | 19.83%2.99B | -2.79%2B | -9.19%2.08B | 19.98%2.21B | 2.59%2.49B | 41.95%2.06B | 19.68%2.29B |
| Transactional financial assets | -19.89%684.57M | -21.78%705.41M | -22.93%615.12M | -90.62%63.29M | -3.85%854.55M | 2,110.41%901.83M | 64.33%798.13M | 536.04%674.35M | 45.42%888.82M | -57.16%40.8M |
| Notes receivable and accounts receivable | -31.72%382.33M | -23.37%357.09M | -27.96%313.71M | -12.43%280.16M | 52.16%559.91M | 5.40%466.02M | 0.08%435.48M | 89.22%319.94M | 18.37%367.96M | 6.82%442.16M |
| -Notes receivable | 32.67%71.79M | 108.79%93.95M | -0.67%81.6M | -53.38%33.79M | 7.75%54.11M | -52.99%45M | 6.63%82.15M | 58.77%72.48M | -45.64%50.22M | -58.12%95.7M |
| -Accounts receivable | -38.60%310.54M | -37.50%263.14M | -34.31%232.11M | -0.44%246.37M | 59.18%505.8M | 21.52%421.03M | -1.33%353.34M | 100.48%247.47M | 45.44%317.75M | 86.87%346.46M |
| Other receivables (including interest and dividends) | 24.55%65.87M | 18.53%70.63M | -23.99%56.07M | -31.72%25.37M | -14.37%52.89M | -12.22%59.59M | 40.54%73.78M | 96.60%37.16M | 6.35%61.76M | 48.38%67.88M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.6M | ---- | ---- |
| -Other receivable | ---- | 18.53%70.63M | ---- | ---- | ---- | -12.22%59.59M | ---- | 51.08%28.56M | ---- | 48.38%67.88M |
| Advance payment | -14.60%65.9M | -10.36%67.35M | -10.38%63.61M | -21.99%53.39M | -27.43%77.17M | -28.03%75.14M | -28.65%70.98M | -1.03%68.44M | 16.20%106.33M | 45.08%104.4M |
| Inventories | 11.96%316.06M | -14.91%291.91M | -15.09%291.25M | -18.66%273.48M | -16.64%282.3M | 2.74%343.07M | 24.53%343.01M | 7.10%336.2M | 14.05%338.65M | 20.64%333.94M |
| Receivable financing | 60.13%112.32M | 31.93%124.84M | 72.74%156.67M | -39.24%54.5M | 38.16%70.14M | -6.49%94.63M | -20.87%90.7M | 21.57%89.7M | -33.01%50.77M | -41.39%101.19M |
| Assets held for sale | --150K | --150K | -99.22%150K | -99.66%150K | ---- | ---- | 200.80%19.34M | 578.96%43.66M | --6.43M | --6.43M |
| Other current assets | -85.68%31.99M | -82.91%37.84M | -77.55%32.54M | -79.63%33.14M | 37.08%223.46M | 34.50%221.38M | -15.89%144.96M | -6.13%162.71M | -67.21%163.01M | -50.10%164.59M |
| Total current assets | -3.21%3.99B | -3.32%4.1B | -5.76%3.94B | -10.75%3.77B | 1.96%4.12B | 19.46%4.24B | 20.17%4.19B | 25.72%4.23B | 19.18%4.04B | 6.96%3.55B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -23.85%13.42M | -22.49%13.66M | 0.91%17.78M | 0.91%17.78M | -6.75%17.62M | -6.75%17.62M | -6.75%17.62M | -6.75%17.62M | 7.02%18.89M | 7.02%18.89M |
| Long-term equity investment | 3.57%137.81M | 1.58%137.71M | 1.70%136.42M | 0.89%135.05M | -26.22%133.07M | -24.89%135.57M | -32.25%134.15M | -15.22%133.86M | 14.55%180.36M | 13.93%180.5M |
| Fixed assets | ---- | -2.55%296.84M | ---- | ---- | ---- | -4.88%304.6M | ---- | 0.14%331.19M | ---- | 3.42%320.23M |
| Constru in process | ---- | 233.86%252.32M | ---- | ---- | ---- | 454.92%75.58M | ---- | 193.93%25.71M | ---- | -51.81%13.62M |
| Intangible assets | 169.57%87.47M | 157.72%87.84M | 147.56%88.07M | 141.73%90.11M | -12.61%32.45M | -9.82%34.08M | -6.49%35.57M | 1.01%37.28M | 11.14%37.13M | 13.87%37.8M |
| Development expenditure | 62.68%97.44M | 52.16%83.35M | 57.47%78.52M | 66.97%71.66M | 58.04%59.9M | 61.31%54.77M | 58.46%49.87M | 41.66%42.92M | 21.08%37.9M | 10.87%33.96M |
| Goodwill | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M | 0.00%25.26M |
| Long deferred expense | -47.39%6.66M | -47.92%7.69M | -44.24%9.29M | -54.94%10.63M | -46.12%12.66M | -41.77%14.77M | -36.48%16.67M | -16.12%23.6M | -38.22%23.5M | -35.83%25.37M |
| Deferred tax assets | -11.75%47.03M | 6.47%54.85M | -9.70%48.59M | -15.25%49.46M | 121.39%53.29M | 89.37%51.52M | 128.98%53.81M | 169.73%58.36M | 16.70%24.07M | 43.16%27.21M |
| Usufruct assets | -22.25%108.37M | -19.93%114.79M | -20.15%120.74M | -20.25%126.36M | -16.66%139.39M | 59.70%143.36M | 57.42%151.2M | 56.92%158.44M | 77.98%167.25M | 11.72%89.77M |
| Other non current assets | 63.65%21.23M | 62.40%22.92M | 55.55%19.61M | 175.76%22.46M | 33.76%12.97M | 54.15%14.11M | -13.93%12.61M | 29.93%8.14M | 418.49%9.7M | 315.54%9.16M |
| Total non current assets | 27.73%1.14B | 25.94%1.1B | 24.39%1.07B | 22.68%1.06B | 3.55%889.67M | 11.45%871.26M | 6.61%858.65M | 12.62%862.38M | 13.72%859.19M | 5.05%781.76M |
| Total assets | 2.28%5.12B | 1.67%5.19B | -0.63%5.01B | -5.08%4.83B | 2.24%5.01B | 18.01%5.11B | 17.62%5.04B | 23.29%5.09B | 18.19%4.9B | 6.61%4.33B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -8.89%32.8M | -32.45%35.8M | -11.70%46.8M | -48.01%45.8M | -59.14%36M | 39.47%53M | -39.91%53M | 0.11%88.1M | -3.19%88.1M | -53.66%38M |
| Notes payable and accounts payable | 77.17%371.48M | 25.22%362.11M | -3.38%276.34M | 1.74%289.69M | -15.90%209.68M | 38.44%289.18M | 7.81%286.01M | 81.56%284.74M | 70.43%249.34M | 15.81%208.89M |
| -Notes payable | 360.42%181.63M | 32.11%151.4M | -60.30%49.03M | -40.21%79.67M | -43.94%39.45M | 371.77%114.6M | 251.88%123.51M | 347.55%133.26M | 1,082.12%70.36M | -39.10%24.29M |
| -Accounts payable | 11.53%189.85M | 20.69%210.71M | 39.88%227.31M | 38.65%210.01M | -4.88%170.23M | -5.43%174.58M | -29.41%162.5M | 19.23%151.47M | 27.52%178.97M | 31.41%184.6M |
| Contract liabilities | -13.01%68.37M | 43.48%85.83M | 57.94%131.52M | -10.60%91.86M | -28.98%78.59M | -49.17%59.82M | -35.84%83.27M | 16.53%102.75M | -54.65%110.66M | -36.11%117.68M |
| Salaries payable | 227.31%22.02M | 221.64%23.49M | 112.54%18.9M | -22.13%23.72M | 1.78%6.73M | 14.50%7.3M | 40.46%8.89M | -9.84%30.46M | 21.86%6.61M | 28.19%6.38M |
| Taxs payable | -15.30%118.03M | -2.49%102.78M | 9.47%101.57M | -40.01%96.39M | -21.20%139.35M | -14.93%105.4M | -6.43%92.78M | -5.03%160.69M | 21.84%176.84M | 17.12%123.91M |
| Other payable (including interest and dividends) | 52.43%69.93M | 27.80%282.99M | -13.61%78.37M | -44.30%80.49M | -36.54%45.88M | -9.97%221.44M | 14.64%90.72M | 49.87%144.5M | -20.50%72.29M | 18.99%245.95M |
| -Dividend payable | 14.32%1.97M | 17.27%178.69M | 201.17%4.55M | 14.41%1.73M | 14.41%1.73M | -0.23%152.38M | -19.19%1.51M | -80.89%1.51M | -80.89%1.51M | 17.10%152.74M |
| -Other payable | ---- | 51.03%104.3M | ---- | ---- | ---- | -25.91%69.06M | ---- | 61.53%142.99M | ---- | 22.21%93.22M |
| Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --3.86M | ---- | ---- | ---- |
| Non current liabilities due within one year | 276.13%131.67M | -26.66%24.17M | 21.04%33.36M | 16.98%32.91M | 31.71%35.01M | 38.14%32.95M | 29.01%27.56M | 33.06%28.13M | 162.66%26.58M | 56.31%23.86M |
| Other current liabilities | 45.23%20.54M | 6.40%20.26M | -9.64%18.06M | 7.69%20.23M | -43.16%14.14M | -13.04%19.05M | 24.40%19.99M | 57.69%18.78M | -12.58%24.88M | 7.28%21.9M |
| Total current liabilities | 47.66%834.84M | 18.94%937.44M | 5.83%704.92M | -20.63%681.07M | -25.15%565.38M | 0.20%788.15M | -5.57%666.08M | 28.96%858.14M | -0.80%755.3M | -1.64%786.57M |
| Current liabilities | ||||||||||
| Long term loan | ---- | -72.58%109.7M | -75.62%99.9M | -75.00%100M | 0.00%400M | --400M | --409.8M | --400M | --400M | ---- |
| Deferred tax liabilities | -16.87%26.37M | -19.37%26.11M | -22.89%27.34M | -19.11%28.61M | 1,337.62%31.72M | 1,321.03%32.38M | 1,407.28%35.45M | 1,307.97%35.37M | -17.44%2.21M | -14.73%2.28M |
| Long term deferred income | 11.55%28.73M | 17.70%30.8M | -2.82%26.03M | 3.49%27.89M | -1.83%25.75M | -4.20%26.16M | -4.31%26.78M | -7.16%26.95M | 74.34%26.23M | 73.87%27.31M |
| Lease liabilities | -29.34%80.62M | -27.82%83.92M | -25.82%88.95M | -23.29%93.59M | -13.41%114.1M | 76.55%116.26M | 67.06%119.91M | 66.65%122M | 55.64%131.76M | 1.12%65.85M |
| Other non current liabilities | -18.30%23.76M | -20.00%23.37M | -24.56%21.6M | -3.66%28.46M | 26.05%29.08M | 17.57%29.21M | 4.72%28.63M | -30.55%29.54M | -21.05%23.07M | -5.01%24.85M |
| Total non current liabilities | -73.45%159.47M | -54.65%273.89M | -57.49%263.81M | -54.62%278.55M | 2.98%600.65M | 402.14%604.02M | 379.37%620.57M | 316.79%613.86M | 310.04%583.27M | -0.01%120.29M |
| Total liabilities | -14.73%994.31M | -12.99%1.21B | -24.71%968.73M | -34.81%959.62M | -12.89%1.17B | 53.52%1.39B | 54.13%1.29B | 81.12%1.47B | 48.13%1.34B | -1.43%906.85M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M | 0.00%431.05M |
| Capital reserve funds | -47.86%29.23M | -53.17%29.13M | -53.70%28.86M | -48.87%51.51M | -45.25%56.06M | -40.00%62.2M | -40.74%62.34M | -4.24%100.74M | 5.38%102.4M | -5.26%103.67M |
| Surplus reserve funds | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M | 0.00%295.29M |
| Retained profit | 10.54%3.24B | 10.75%3.1B | 10.57%3.16B | 10.97%2.96B | 12.66%2.93B | 13.69%2.8B | 15.24%2.85B | 13.96%2.67B | 16.15%2.6B | 15.54%2.46B |
| Other composite income | -8.51%2.59M | -4.94%2.76M | 21.73%2.66M | 8.04%2.66M | 7.52%2.83M | 55.23%2.9M | 85.49%2.19M | 91.91%2.46M | 72.46%2.64M | 23.51%1.87M |
| Shareholders equity without minority interests | 7.59%4B | 7.45%3.86B | 7.37%3.91B | 6.96%3.74B | 8.25%3.72B | 9.00%3.59B | 10.14%3.64B | 10.19%3.49B | 12.01%3.44B | 10.97%3.29B |
| Minority interests | 3.16%129.75M | -1.07%126.82M | 15.37%130.45M | 8.59%131.94M | -0.86%125.77M | -1.47%128.2M | -21.81%113.07M | -14.92%121.5M | -27.96%126.86M | -25.18%130.11M |
| Other items effecting shareholder equity | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total shareholder equity | 7.44%4.13B | 7.16%3.98B | 7.61%4.04B | 7.02%3.87B | 7.93%3.84B | 8.60%3.72B | 8.80%3.76B | 9.11%3.62B | 9.84%3.56B | 8.97%3.42B |
| Total liabilityies and equity | 2.28%5.12B | 1.67%5.19B | -0.63%5.01B | -5.08%4.83B | 2.24%5.01B | 18.01%5.11B | 17.62%5.04B | 23.29%5.09B | 18.19%4.9B | 6.61%4.33B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
